Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
about
Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acidBone loss associated with use of antiepileptic drugs.Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.
P2860
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
@en
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
@nl
type
label
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
@en
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
@nl
prefLabel
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
@en
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
@nl
P2093
P2860
P356
P1476
Serum and muscle carnitine levels in epileptic children receiving sodium valproate.
@en
P2093
Ayse Berna Anil
Ebru Ozbal
Mehmet Helvaci
Murat Anil
Mustafa Dilek
Onder Kalenderer
P2860
P356
10.1177/0883073808321060
P577
2009-01-01T00:00:00Z